Cadrenal Therapeutics, Inc. (NasdaqCM: CVKD)
Health Care · Pharmaceuticals · US
$0.82
-10.19% today · -93.3% 1Y
Cadrenal Therapeutics, Inc. (NasdaqCM: CVKD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.25M and employs 5 people.
Over the last twelve months the share price has lost 93.3%, trading between 0.85 and 14.50.
Tweenvest scores Cadrenal Therapeutics, Inc. across four factors: quality 44/100, value 29/100. Its strongest factor is quality.
CVKD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.25M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.86
- Dividend yield
- —
- Beta (5Y)
- 1.95
- 52-week high
- $14.50
- 52-week low
- $0.85
- Avg volume (3M)
- —
- Shares outstanding
- 3.57M
- Employees
- 5
- Next earnings
- —
About Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
- ISIN
- US1276362076
- Founded
- 2022
- Listed since
- Jan 20, 2023
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CTT Pharmaceutical Holdings, Inc.OTCPK: CTTH | $3.38M | $0.06 | +2.91% |
| ODI Pharma AB (publ)NGM: ODI | $3.32M | Skr1.81 | -7.18% |
| Sanai Health Industry Group Company LimitedSEHK: 1889 | $3.31M | HK$0.17 | -10.99% |
| RedHill Biopharma Ltd.NasdaqCM: RDHL | $3.28M | $0.52 | -2.69% |
| Goldline Pharmaceutical LimitedBSE: 544759 | $3.22M | Rs32.50 | +4.94% |
| Herbal Dispatch Inc.CNSX: HERB | $3.21M | CA$0.04 | +16.67% |
| PRF Technologies Ltd.NasdaqCM: PRFX | $3.08M | $0.86 | -2.33% |
| Grey Matters Health Inc.CNSX: GREY | $3.05M | CA$0.39 | +1.32% |
Figures last refreshed Oct 11, 2026.